Antifungal Activity and Pharmacokinetics of Posaconazole (SCH 56592) in Treatment and Prevention of Experimental Invasive Pulmonary Aspergillosis: Correlation with Galactomannan Antigenemia

類似資料

• Antifungal Efficacy of Caspofungin (MK-0991) in Experimental Pulmonary Aspergillosis in Persistently Neutropenic Rabbits: Pharmacokinetics, Drug Disposition, and Relationship to Galactomannan Antigenemia
  著者:: Petraitiene, Ruta, 等
  出版事項: (2002)
• Galactomannan Antigenemia in Pediatric Oncology Patients With Invasive Aspergillosis
  著者:: Hayden, Randall, 等
  出版事項: (2008)
• Pharmacodynamics of Posaconazole in Experimental Invasive Pulmonary Aspergillosis: Utility of Serum Galactomannan as a Dynamic Endpoint of Antifungal Efficacy
  著者:: Gastine, Silke, 等
  出版事項: (2021)
• Galactomannan Antigenemia after Infusion of Gluconate-Containing Plasma-Lyte
  著者:: Petraitiene, Ruta, 等
  出版事項: (2011)
• Detection of Galactomannan Antigenemia in Patients Receiving Piperacillin-Tazobactam and Correlations between In Vitro, In Vivo, and Clinical Properties of the Drug-Antigen Interaction
  著者:: Walsh, Thomas J., 等
  出版事項: (2004)